Position in ZTS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$6,478,035
-$4,039,581 QoQ
Shares Held
90,148
+1.3% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#298
of 1,412 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEB Asset Management AB holds $105,165,290 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,695,648 | $57,448,554 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
176,754 | $29,790,119 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
12,523 | $6,785,337 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
90,148 | $6,478,035 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
56,333 | $4,663,245 |
All Filings in ZTS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,478,035 | 90,148 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $10,517,616 | 88,974 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||